InvestorsHub Logo
Followers 94
Posts 2735
Boards Moderated 0
Alias Born 09/15/2020

Re: Dan88 post# 309080

Friday, 09/18/2020 11:10:44 PM

Friday, September 18, 2020 11:10:44 PM

Post# of 693013
Dan, I think you are right in your assessment. As far as I can tell, AF have feasted on articles after/during Phase I/II Trials and not when TLD for phase III trials have been published. At that point, it will only be an uphill battle as any movement down after a successful reveal will be temporary (Which will cover some shorts) as the media will be thrilled to report on a potential cancer treatment that can extend survival rate for patients.

I just hope that all the good people in here will take their time and look at the experts review of TLD and not fall for the scare tactics and lose out on the profit they deserve after staying with this company so long.

The fluctuation in SP both ways this week has probably more to do with technicals than anything else. The last possitive news about financing and Flaskworks acquisition happened way before this week.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News